This is a table of type unigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| unigram | frequency |
|---|---|
| patients | 92014 |
| study | 47684 |
| results | 36622 |
| cells | 27439 |
| using | 26670 |
| group | 24885 |
| blood | 24082 |
| treatment | 23243 |
| studies | 22578 |
| may | 21948 |
| data | 21507 |
| clinical | 20957 |
| used | 20784 |
| cell | 20647 |
| also | 20232 |
| one | 19855 |
| methods | 19675 |
| disease | 19190 |
| two | 19052 |
| patient | 18861 |
| analysis | 18622 |
| associated | 18348 |
| time | 17927 |
| high | 16486 |
| cases | 16383 |
| years | 16293 |
| age | 15909 |
| compared | 15708 |
| performed | 15257 |
| risk | 15247 |
| significant | 14858 |
| use | 14609 |
| care | 14298 |
| increased | 14284 |
| levels | 14152 |
| protein | 13955 |
| expression | 13921 |
| found | 13845 |
| i | 13828 |
| mean | 13704 |
| different | 13281 |
| based | 13099 |
| however | 13086 |
| showed | 13039 |
| control | 12868 |
| non | 12788 |
| hospital | 12772 |
| conclusion | 12547 |
| will | 12327 |
| well | 12216 |
| activity | 11953 |
| days | 11828 |
| higher | 11826 |
| significantly | 11677 |
| health | 11587 |
| groups | 11553 |
| positive | 11184 |
| children | 11170 |
| therapy | 11159 |
| effect | 10998 |
| first | 10762 |
| system | 10673 |
| effects | 10561 |
| ml | 10166 |
| human | 10158 |
| case | 10134 |
| infection | 10079 |
| specific | 10059 |
| day | 9986 |
| rate | 9901 |
| low | 9878 |
| included | 9876 |
| method | 9869 |
| due | 9737 |
| total | 9736 |
| related | 9677 |
| three | 9672 |
| number | 9653 |
| reported | 9611 |
| level | 9536 |
| observed | 9516 |
| cd | 9446 |
| response | 9421 |
| acute | 9420 |
| diagnosis | 9374 |
| type | 9333 |
| cancer | 9309 |
| mortality | 9286 |
| without | 9278 |
| test | 9245 |
| including | 9216 |
| present | 9194 |
| icu | 9105 |
| vs | 9002 |
| role | 8994 |
| increase | 8905 |
| factors | 8858 |
| mg | 8837 |
| new | 8781 |
| respectively | 8673 |
| function | 8661 |
| normal | 8656 |
| months | 8644 |
| research | 8629 |
| among | 8580 |
| within | 8553 |
| medical | 8533 |
| severe | 8510 |
| following | 8486 |
| anti | 8450 |
| il | 8417 |
| surgery | 8341 |
| model | 8308 |
| treated | 8131 |
| important | 8080 |
| identified | 8074 |
| changes | 8006 |
| samples | 7826 |
| potential | 7788 |
| gene | 7742 |
| lung | 7678 |
| lower | 7650 |
| respiratory | 7642 |
| year | 7641 |
| early | 7628 |
| conclusions | 7615 |
| induced | 7609 |
| mice | 7531 |
| ct | 7528 |
| aim | 7502 |
| period | 7398 |
| post | 7365 |
| tissue | 7284 |
| dose | 7280 |
| development | 7274 |
| outcome | 7206 |
| serum | 7162 |
| brain | 7146 |
| findings | 7098 |
| negative | 7042 |
| imaging | 7015 |
| population | 6955 |
| measured | 6953 |
| range | 6933 |
| common | 6922 |
| plasma | 6850 |
| primary | 6797 |
| proteins | 6790 |
| introduction | 6764 |
| review | 6739 |
| university | 6709 |
| injury | 6689 |
| renal | 6671 |
| obtained | 6573 |
| quality | 6544 |
| score | 6515 |
| presence | 6462 |
| chronic | 6391 |
| asthma | 6385 |
| information | 6362 |
| evidence | 6298 |
| background | 6223 |
| shown | 6221 |
| liver | 6177 |
| small | 6110 |
| evaluated | 6099 |
| symptoms | 6096 |
| factor | 6050 |
| differences | 6022 |
| single | 6015 |
| management | 6012 |
| outcomes | 5935 |
| developed | 5896 |
| similar | 5857 |
| surgical | 5853 |
| several | 5798 |
| hours | 5759 |
| kg | 5758 |
| tumor | 5740 |
| reduced | 5739 |
| although | 5733 |
| median | 5727 |
| transfusion | 5726 |
| less | 5704 |
| inflammatory | 5688 |
| drug | 5639 |
| dna | 5594 |
| pressure | 5570 |
| covid | 5562 |
| difference | 5562 |
| determine | 5549 |
| acid | 5508 |
| infections | 5474 |
| cardiac | 5459 |
| follow | 5451 |
| subjects | 5426 |
| decreased | 5423 |
| objective | 5422 |
| syndrome | 5407 |
| ii | 5342 |
| approach | 5329 |
| studied | 5306 |
| revealed | 5299 |
| diseases | 5296 |
| pulmonary | 5290 |
| detected | 5285 |
| known | 5270 |
| values | 5265 |
| received | 5264 |
| possible | 5252 |
| many | 5249 |
| considered | 5248 |
| major | 5238 |
| standard | 5218 |
| women | 5214 |
| mm | 5213 |
| failure | 5196 |
| complications | 5180 |
| large | 5163 |
| evaluation | 5157 |
| report | 5109 |
| evaluate | 5068 |
| process | 5065 |
| according | 5063 |
| four | 5057 |
| addition | 5047 |
| receptor | 5043 |
| long | 5043 |
| collected | 5037 |
| volume | 5031 |
| determined | 5025 |
| activation | 4994 |
| assessment | 4988 |
| incidence | 4932 |
| ci | 4929 |
| therefore | 4920 |
| multiple | 4919 |
| value | 4907 |
| association | 4900 |
| assessed | 4865 |
| molecular | 4865 |
| parameters | 4842 |
| min | 4841 |
| whether | 4840 |
| suggest | 4818 |
| presented | 4814 |
| order | 4797 |
| demonstrated | 4795 |
| term | 4788 |
| per | 4786 |
| life | 4776 |
| conditions | 4770 |
| correlation | 4759 |
| old | 4720 |
| criteria | 4685 |
| production | 4674 |
| available | 4658 |
| pre | 4657 |
| th | 4653 |
| impact | 4643 |
| weeks | 4628 |
| support | 4624 |
| binding | 4619 |
| body | 4583 |
| effective | 4570 |
| survival | 4563 |
| either | 4559 |
| show | 4554 |
| weight | 4535 |
| work | 4534 |
| dogs | 4532 |
| resistance | 4527 |
| cause | 4527 |
| like | 4507 |
| admission | 4497 |
| size | 4494 |
| rates | 4486 |
| concentration | 4474 |
| assess | 4468 |
| healthy | 4461 |
| analyzed | 4452 |
| safety | 4448 |
| pain | 4446 |
| administration | 4436 |
| change | 4433 |
| investigated | 4428 |
| exposure | 4427 |
| reduction | 4427 |
| procedure | 4426 |
| prevalence | 4413 |
| immune | 4403 |
| involved | 4382 |
| diagnostic | 4379 |
| lesions | 4374 |
| therapeutic | 4369 |
| genes | 4362 |
| membrane | 4361 |
| detection | 4359 |
| contrast | 4336 |
| growth | 4330 |
| controls | 4327 |
| virus | 4327 |
| participants | 4327 |
| need | 4305 |
| followed | 4302 |
| current | 4290 |
| various | 4289 |
| flow | 4266 |
| department | 4256 |
| tested | 4250 |
| phase | 4241 |
| male | 4237 |
| antibodies | 4236 |
| general | 4231 |
| initial | 4231 |
| concentrations | 4226 |
| required | 4215 |
| mri | 4196 |
| overall | 4194 |
| average | 4189 |
| since | 4170 |
| pcr | 4164 |
| unit | 4143 |
| trauma | 4134 |
| intervention | 4130 |
| donors | 4127 |
| functional | 4126 |
| sample | 4104 |
| status | 4096 |
| rats | 4091 |
| provide | 4081 |
| antibody | 4068 |
| objectives | 4062 |
| result | 4061 |
| testing | 4057 |
| identify | 4054 |
| sepsis | 4050 |
| ratio | 4041 |
| decrease | 4023 |
| vitro | 4018 |
| loss | 4012 |
| often | 4000 |
| defined | 3990 |
| technique | 3947 |
| underwent | 3931 |
| conducted | 3913 |
| intensive | 3913 |
| prior | 3909 |
| design | 3895 |
| peptide | 3893 |
| second | 3876 |
| death | 3872 |
| co | 3844 |
| baseline | 3843 |
| dependent | 3836 |
| laboratory | 3823 |
| trial | 3822 |
| novel | 3811 |
| severity | 3809 |
| center | 3808 |
| complex | 3804 |
| isolated | 3773 |
| given | 3747 |
| purpose | 3705 |
| platelet | 3704 |
| heart | 3703 |
| described | 3703 |
| tests | 3701 |
| additional | 3697 |
| via | 3694 |
| free | 3691 |
| muscle | 3678 |
| surface | 3673 |
| cohort | 3663 |
| examined | 3663 |
| left | 3661 |
| bone | 3660 |
| even | 3629 |
| least | 3623 |
| end | 3611 |
| critical | 3609 |
| right | 3608 |
| inflammation | 3607 |
| area | 3600 |
| duration | 3595 |
| us | 3594 |
| active | 3576 |
| structure | 3563 |
| history | 3555 |
| previous | 3555 |
| ed | 3543 |
| characteristics | 3542 |
| sensitivity | 3540 |
| better | 3540 |
| animals | 3539 |
| mass | 3533 |
| female | 3526 |
| main | 3525 |
| stress | 3525 |
| assay | 3521 |
| procedures | 3504 |
| adult | 3497 |
| family | 3495 |
| expressed | 3492 |
| screening | 3490 |
| viral | 3489 |
| formation | 3489 |
| derived | 3473 |
| practice | 3471 |
| improved | 3463 |
| protocol | 3454 |
| seen | 3449 |
| confirmed | 3448 |
| five | 3444 |
| efficacy | 3429 |
| index | 3425 |
| admitted | 3419 |
| good | 3400 |
| might | 3394 |
| previously | 3388 |
| retrospective | 3385 |
| oral | 3385 |
| improve | 3385 |
| examination | 3385 |
| part | 3384 |
| increasing | 3382 |
| mechanism | 3378 |
| table | 3375 |
| site | 3375 |
| prospective | 3373 |
| medicine | 3372 |
| target | 3371 |
| cm | 3371 |
| recent | 3367 |
| bacterial | 3354 |
| frequency | 3352 |
| vivo | 3348 |
| investigate | 3345 |
| length | 3344 |
| ventilation | 3326 |
| scale | 3322 |
| airway | 3318 |
| ca | 3310 |
| mechanisms | 3309 |
| stage | 3308 |
| models | 3307 |
| events | 3307 |
| stay | 3294 |
| drugs | 3290 |
| responses | 3288 |
| pediatric | 3264 |
| diagnosed | 3263 |
| made | 3257 |
| secondary | 3255 |
| physical | 3246 |
| culture | 3241 |
| likely | 3232 |
| improvement | 3225 |
| limited | 3212 |
| comparison | 3199 |
| rna | 3198 |
| social | 3180 |
| units | 3172 |
| greater | 3171 |
| key | 3168 |
| adverse | 3163 |
| region | 3145 |
| form | 3141 |
| scores | 3136 |
| national | 3135 |
| whereas | 3130 |
| skin | 3130 |
| monitoring | 3124 |
| evs | 3117 |
| especially | 3116 |
| vascular | 3105 |
| literature | 3098 |
| invasive | 3093 |
| relationship | 3088 |
| systems | 3078 |
| food | 3071 |
| still | 3064 |
| six | 3063 |
| caused | 3060 |
| glucose | 3049 |
| types | 3045 |
| reduce | 3043 |
| ms | 3042 |
| diabetes | 3036 |
| emergency | 3028 |
| adults | 3026 |
| genetic | 3022 |
| authors | 3020 |
| randomized | 3020 |
| combination | 3018 |
| local | 3012 |
| fluid | 3011 |
| controlled | 3009 |
| kidney | 3002 |
| highly | 2994 |
| include | 2991 |
| times | 2984 |
| shock | 2982 |
| whole | 2977 |
| state | 2972 |
| poor | 2971 |
| peptides | 2966 |
| features | 2966 |
| guidelines | 2961 |
| influence | 2959 |
| knowledge | 2957 |
| central | 2949 |
| mediated | 2946 |
| abdominal | 2944 |
| versus | 2942 |
| applied | 2942 |
| useful | 2940 |
| daily | 2935 |
| needed | 2933 |
| analyses | 2930 |
| recently | 2926 |
| training | 2921 |
| products | 2907 |
| strains | 2899 |
| laparoscopic | 2892 |
| calculated | 2891 |
| measurements | 2891 |
| month | 2886 |
| images | 2884 |
| measures | 2868 |
| cellular | 2868 |
| individual | 2853 |
| selected | 2853 |
| reaction | 2848 |
| tumors | 2841 |
| statistical | 2836 |
| course | 2836 |
| despite | 2819 |
| ae | 2815 |
| release | 2807 |
| postoperative | 2789 |
| people | 2786 |
| recorded | 2786 |
| individuals | 2776 |
| short | 2775 |
| experience | 2767 |
| breast | 2766 |
| self | 2761 |
| fi | 2760 |
| species | 2757 |
| techniques | 2750 |
| oxygen | 2745 |
| markers | 2743 |
| grade | 2735 |
| material | 2730 |
| characterized | 2723 |
| trials | 2714 |
| furthermore | 2713 |
| hiv | 2711 |
| interaction | 2711 |
| independent | 2708 |
| provided | 2704 |
| complete | 2702 |
| peripheral | 2698 |
| biological | 2690 |
| distribution | 2686 |
| rare | 2686 |
| amino | 2684 |
| organ | 2681 |
| cross | 2676 |
| side | 2675 |
| regarding | 2674 |
| pneumonia | 2674 |
| correlated | 2669 |
| line | 2666 |
| water | 2659 |
| systematic | 2650 |
| properties | 2650 |
| point | 2646 |
| week | 2640 |
| able | 2636 |
| donor | 2626 |
| statistically | 2619 |
| materials | 2619 |
| agents | 2618 |
| established | 2617 |
| application | 2616 |
| ability | 2611 |
| mouse | 2611 |
| tool | 2608 |
| metabolic | 2608 |
| regression | 2607 |
| septic | 2606 |
| mrna | 2603 |
| areas | 2602 |
| community | 2597 |
| mutations | 2593 |
| resistant | 2591 |
| direct | 2588 |
| interventions | 2586 |
| program | 2580 |
| japan | 2577 |
| hand | 2562 |
| elevated | 2558 |
| affected | 2554 |
| onset | 2554 |
| sequence | 2550 |
| cost | 2543 |
| biopsy | 2543 |
| identification | 2541 |
| antigen | 2540 |
| receptors | 2537 |
| arterial | 2537 |
| containing | 2534 |
| pathway | 2533 |
| sd | 2530 |
| pregnancy | 2525 |
| cerebral | 2524 |
| mechanical | 2513 |
| systemic | 2509 |
| taken | 2503 |
| iv | 2502 |
| performance | 2502 |
| inhibition | 2501 |
| older | 2501 |
| another | 2499 |
| ph | 2498 |
| enzyme | 2496 |
| disorders | 2491 |
| lead | 2483 |
| reviewed | 2481 |
| pattern | 2481 |
| experimental | 2476 |
| red | 2472 |
| dysfunction | 2470 |
| antibiotic | 2467 |
| bacteria | 2466 |
| relevant | 2465 |
| neurons | 2464 |
| variables | 2457 |
| image | 2447 |
| delivery | 2447 |
| lack | 2444 |
| artery | 2444 |
| future | 2443 |
| interest | 2439 |
| appropriate | 2431 |
| animal | 2426 |
| damage | 2421 |
| produced | 2413 |
| set | 2403 |
| tract | 2400 |
| done | 2394 |
| last | 2390 |
| uptake | 2389 |
| components | 2384 |
| infected | 2383 |
| ill | 2381 |
| carried | 2379 |
| regulation | 2373 |
| tnf | 2372 |
| indicate | 2369 |
| urinary | 2365 |
| activities | 2361 |
| proliferation | 2359 |
| frequent | 2359 |
| minutes | 2353 |
| gastric | 2351 |
| molecules | 2349 |
| ultrasound | 2347 |
| synthesis | 2345 |
| tissues | 2337 |
| survey | 2332 |
| mutation | 2332 |
| injection | 2330 |
| stroke | 2327 |
| carcinoma | 2325 |
| analysed | 2323 |
| healthcare | 2318 |
| specificity | 2317 |
| rat | 2312 |
| remains | 2310 |
| tumour | 2306 |
| occurred | 2305 |
| causes | 2302 |
| fibrosis | 2298 |
| antibiotics | 2295 |
| condition | 2287 |
| necessary | 2284 |
| temperature | 2283 |
| clinically | 2278 |
| compare | 2276 |
| currently | 2268 |
| chest | 2264 |
| published | 2263 |
| presentation | 2263 |
| absence | 2261 |
| administered | 2260 |
| insulin | 2255 |
| isolates | 2254 |
| processes | 2249 |
| meta | 2244 |
| series | 2236 |
| doses | 2235 |
| indicated | 2235 |
| develop | 2235 |
| prevention | 2232 |
| must | 2231 |
| hcv | 2225 |
| resulted | 2224 |
| help | 2220 |
| later | 2219 |
| quantitative | 2217 |
| enhanced | 2217 |
| across | 2209 |
| ng | 2207 |
| bleeding | 2203 |
| fold | 2201 |
| experiments | 2199 |
| cord | 2198 |
| mild | 2197 |
| moderate | 2195 |
| operative | 2194 |
| measure | 2192 |
| activated | 2192 |
| measurement | 2187 |
| combined | 2185 |
| lipid | 2185 |
| best | 2182 |
| education | 2181 |
| setting | 2177 |
| importance | 2175 |
| signs | 2174 |
| venous | 2171 |
| morbidity | 2169 |
| aged | 2166 |
| moreover | 2165 |
| iii | 2162 |
| conventional | 2159 |
| play | 2157 |
| institute | 2156 |
| rapid | 2153 |
| suggested | 2152 |
| catheter | 2152 |
| hypertension | 2151 |
| frequently | 2147 |
| essential | 2136 |
| suggests | 2130 |
| leading | 2125 |
| resolution | 2124 |
| nerve | 2124 |
| interactions | 2123 |
| particularly | 2123 |
| shows | 2123 |
| inhibitor | 2121 |
| relative | 2121 |
| sites | 2119 |
| majority | 2118 |
| understanding | 2115 |
| cftr | 2113 |
| pathology | 2112 |
| routine | 2107 |
| infectious | 2084 |
| discharge | 2083 |
| epithelial | 2082 |
| reactions | 2077 |
| implementation | 2073 |
| resulting | 2071 |
| countries | 2069 |
| men | 2069 |
| reports | 2068 |
| aims | 2067 |
| stable | 2066 |
| extracellular | 2065 |
| critically | 2061 |
| regions | 2058 |
| demonstrate | 2056 |
| mr | 2053 |
| dl | 2052 |
| medication | 2052 |
| influenza | 2052 |
| real | 2047 |
| structural | 2044 |
| field | 2043 |
| stimulation | 2042 |
| patterns | 2038 |
| estimated | 2036 |
| cats | 2031 |
| suggesting | 2028 |
| sensitive | 2021 |
| pet | 2021 |
| hospitals | 2020 |
| describe | 2015 |
| inhibitors | 2012 |
| reference | 2012 |
| designed | 2005 |
| staff | 2005 |
| compounds | 2005 |
| problems | 2003 |
| collection | 2003 |
| head | 2003 |
| open | 2001 |
| phenotype | 1999 |
| cultures | 1998 |
| beta | 1997 |
| transmission | 1996 |
| urine | 1995 |
| lps | 1991 |
| content | 1988 |
| increases | 1984 |
| investigation | 1982 |
| recovery | 1981 |
| alone | 1980 |
| acids | 1979 |
| signal | 1975 |
| every | 1973 |
| light | 1970 |
| services | 1970 |
| action | 1969 |
| young | 1968 |
| safe | 1964 |
| strategies | 1958 |
| public | 1954 |
| stem | 1952 |
| developing | 1948 |
| subsequent | 1946 |
| particular | 1945 |
| males | 1945 |
| infusion | 1942 |
| commonly | 1940 |
| summary | 1938 |
| infants | 1929 |
| involvement | 1928 |
| mainly | 1928 |
| full | 1927 |
| pts | 1922 |
| provides | 1920 |
| cytokines | 1919 |
| progression | 1918 |
| ev | 1916 |
| access | 1915 |
| product | 1910 |
| sex | 1907 |
| effectiveness | 1906 |
| position | 1902 |
| exposed | 1901 |
| terms | 1900 |
| neurological | 1899 |
| bmi | 1899 |
| affect | 1896 |
| lesion | 1894 |
| degree | 1894 |
| placebo | 1888 |
| solution | 1883 |
| supported | 1883 |
| igg | 1881 |
| hepatic | 1881 |
| continuous | 1880 |
| usually | 1880 |
| alternative | 1874 |
| percentage | 1864 |
| prevent | 1862 |
| difficult | 1862 |
| service | 1856 |
| transplantation | 1853 |
| microscopy | 1851 |
| step | 1848 |
| way | 1845 |
| cytokine | 1844 |
| structures | 1843 |
| aimed | 1842 |
| strong | 1841 |
| domain | 1840 |
| females | 1840 |
| questionnaire | 1838 |
| perfusion | 1835 |
| example | 1834 |
| achieved | 1833 |
| scan | 1833 |
| allergic | 1832 |
| environment | 1831 |
| see | 1829 |
| media | 1829 |
| now | 1827 |
| excluded | 1825 |
| cardiovascular | 1821 |
| receiving | 1817 |
| accuracy | 1816 |
| technology | 1813 |
| third | 1812 |
| seven | 1810 |
| prognosis | 1810 |
| noted | 1807 |
| medium | 1804 |
| fat | 1804 |
| learning | 1801 |
| energy | 1800 |
| malignant | 1791 |
| detect | 1791 |
| density | 1785 |
| upper | 1785 |
| lines | 1784 |
| differentiation | 1784 |
| points | 1782 |
| contribute | 1777 |
| date | 1776 |
| abnormalities | 1775 |
| marker | 1774 |
| apoptosis | 1766 |
| acquired | 1765 |
| occur | 1764 |
| signaling | 1764 |
| resection | 1758 |
| strategy | 1757 |
| induction | 1757 |
| completed | 1754 |
| potentially | 1751 |
| consistent | 1750 |
| natural | 1748 |
| highest | 1744 |
| double | 1743 |
| consecutive | 1743 |
| underlying | 1740 |
| enrolled | 1740 |
| fetal | 1737 |
| lymph | 1735 |
| amount | 1732 |
| complication | 1730 |
| pathways | 1729 |
| expected | 1728 |
| assays | 1727 |
| count | 1727 |
| international | 1726 |
| pro | 1724 |
| illness | 1723 |
| rbc | 1723 |
| copd | 1719 |
| air | 1717 |
| injuries | 1714 |
| sars | 1713 |
| predicted | 1711 |
| none | 1711 |
| wide | 1711 |
| mental | 1709 |
| modified | 1709 |
| alpha | 1708 |
| means | 1706 |
| signifi | 1706 |
| optimal | 1703 |
| states | 1703 |
| wall | 1701 |
| significance | 1699 |
| world | 1699 |
| platelets | 1698 |
| january | 1698 |
| approximately | 1696 |
| diet | 1694 |
| allows | 1692 |
| capacity | 1687 |
| mmhg | 1683 |
| much | 1682 |
| compliance | 1681 |
| coronary | 1681 |
| finding | 1680 |
| abnormal | 1679 |
| endothelial | 1679 |
| antimicrobial | 1678 |
| chain | 1678 |
| proposed | 1677 |
| basis | 1676 |
| nm | 1673 |
| search | 1669 |
| longer | 1668 |
| problem | 1667 |
| usa | 1666 |
| specimens | 1665 |
| mir | 1664 |
| proportion | 1662 |
| towards | 1661 |
| hepatitis | 1660 |
| fluorescence | 1660 |
| team | 1658 |
| together | 1657 |
| directly | 1655 |
| global | 1655 |
| profile | 1654 |
| challenge | 1653 |
| host | 1651 |
| half | 1648 |
| functions | 1646 |
| multi | 1646 |
| gender | 1646 |
| predictive | 1645 |
| cystic | 1641 |
| late | 1640 |
| died | 1638 |
| metabolism | 1637 |
| populations | 1631 |
| nurses | 1627 |
| class | 1623 |
| divided | 1623 |
| variation | 1622 |
| decision | 1619 |
| needs | 1618 |
| er | 1618 |
| responsible | 1617 |
| cognitive | 1614 |
| operation | 1614 |
| inclusion | 1613 |
| linked | 1613 |
| transfer | 1610 |
| database | 1606 |
| germany | 1606 |
| benefit | 1604 |
| european | 1603 |
| observational | 1602 |
| reactive | 1601 |
| tube | 1601 |
| calcium | 1600 |
| intestinal | 1598 |
| eight | 1596 |
| unknown | 1595 |
| radiation | 1594 |
| yet | 1592 |
| finally | 1592 |
| source | 1592 |
| st | 1590 |
| hr | 1588 |
| obesity | 1582 |
| recommended | 1581 |
| larger | 1578 |
| school | 1578 |
| allow | 1577 |
| predict | 1576 |
| device | 1574 |
| physicians | 1573 |
| disorder | 1570 |
| sequences | 1566 |
| ards | 1566 |
| led | 1565 |
| peak | 1562 |
| pathogens | 1561 |
| suspected | 1558 |
| approaches | 1558 |
| staining | 1556 |
| around | 1554 |
| hour | 1552 |
| humans | 1551 |
| undergoing | 1551 |
| selection | 1550 |
| seems | 1549 |
| centre | 1549 |
| neuronal | 1546 |
| context | 1544 |
| project | 1544 |
| focus | 1544 |
| vaccine | 1544 |
| final | 1543 |
| intravenous | 1542 |
| linear | 1540 |
| sequencing | 1536 |
| software | 1535 |
| become | 1533 |
| clear | 1527 |
| transport | 1527 |
| differential | 1527 |
| internal | 1527 |
| others | 1525 |
| generated | 1525 |
| traumatic | 1525 |
| variable | 1524 |
| stability | 1522 |
| birth | 1521 |
| clinic | 1519 |
| generation | 1518 |
| repair | 1516 |
| component | 1516 |
| elisa | 1514 |
| rt | 1509 |
| macrophages | 1508 |
| contact | 1505 |
| remained | 1503 |
| nasal | 1503 |
| fever | 1502 |
| agent | 1502 |
| successful | 1497 |
| iron | 1497 |
| physiological | 1496 |
| partial | 1494 |
| chemotherapy | 1494 |
| vitamin | 1491 |
| issues | 1489 |
| mixed | 1489 |
| students | 1489 |
| little | 1487 |
| preliminary | 1485 |
| discussion | 1482 |
| hemorrhage | 1481 |
| induce | 1479 |
| abstract | 1479 |
| susceptibility | 1478 |
| transplant | 1477 |
| prognostic | 1476 |
| maximum | 1475 |
| elderly | 1474 |
| western | 1472 |
| members | 1472 |
| exercise | 1471 |
| donation | 1467 |
| hypothesis | 1466 |
| relatively | 1464 |
| appears | 1464 |
| secretion | 1460 |
| experienced | 1459 |
| nature | 1459 |
| nuclear | 1456 |
| chemical | 1455 |
| forms | 1454 |
| strain | 1453 |
| rather | 1449 |
| treatments | 1447 |
| intracellular | 1447 |
| along | 1444 |
| environmental | 1440 |
| depression | 1440 |
| motor | 1438 |
| pandemic | 1434 |
| pathogenesis | 1434 |
| child | 1434 |
| terminal | 1431 |
| questions | 1430 |
| intensity | 1423 |
| colon | 1422 |
| prolonged | 1421 |
| enzymes | 1421 |
| additionally | 1420 |
| arrest | 1418 |
| presenting | 1418 |
| reducing | 1418 |
| regional | 1418 |
| hbv | 1417 |
| making | 1416 |
| maternal | 1414 |
| fractures | 1414 |
| indicating | 1410 |
| advanced | 1407 |
| storage | 1402 |
| therapies | 1401 |
| make | 1400 |
| toxicity | 1400 |
| home | 1399 |
| next | 1398 |
| protective | 1397 |
| recurrence | 1395 |
| strongly | 1394 |
| pd | 1394 |
| variety | 1392 |
| histological | 1392 |
| examine | 1389 |
| cov | 1386 |
| solid | 1385 |
| event | 1384 |
| require | 1384 |
| myocardial | 1383 |
| wt | 1382 |
| twenty | 1380 |
| delayed | 1380 |
| records | 1380 |
| uk | 1379 |
| bowel | 1379 |
| pathological | 1379 |
| united | 1379 |
| costs | 1377 |
| antigens | 1375 |
| reporting | 1375 |
| understand | 1371 |
| extent | 1367 |
| white | 1367 |
| occurs | 1367 |
| deficiency | 1366 |
| ige | 1366 |
| represent | 1366 |
| numbers | 1362 |
| marrow | 1358 |
| coronavirus | 1355 |
| pg | 1355 |
| selective | 1353 |
| comparing | 1352 |
| perform | 1352 |
| transcription | 1351 |
| simple | 1349 |
| certain | 1346 |
| located | 1344 |
| classified | 1342 |
| coli | 1342 |
| requiring | 1339 |
| distinct | 1339 |
| relation | 1338 |
| electron | 1335 |
| psychological | 1334 |
| almost | 1333 |
| communication | 1332 |
| cultured | 1332 |
| corresponding | 1332 |
| repeated | 1331 |
| spontaneous | 1329 |
| interval | 1327 |
| plant | 1326 |
| accurate | 1324 |
| processing | 1324 |
| widely | 1323 |
| spectrum | 1323 |
| specifically | 1323 |
| leads | 1322 |
| pregnant | 1320 |
| genotype | 1320 |
| centers | 1319 |
| clearance | 1318 |
| ifn | 1318 |
| pathogen | 1318 |
| fl | 1317 |
| recommendations | 1317 |
| comparable | 1316 |
| successfully | 1312 |
| remaining | 1312 |
| settings | 1310 |
| dynamic | 1309 |
| ten | 1306 |
| viruses | 1304 |
| episodes | 1303 |
| behavior | 1303 |
| unique | 1302 |
| pancreatic | 1301 |
| subject | 1300 |
| adherence | 1300 |
| variants | 1300 |
| location | 1299 |
| csf | 1298 |
| generally | 1298 |
| distal | 1298 |
| classification | 1298 |
| adequate | 1297 |
| regulatory | 1297 |
| aureus | 1297 |
| tumours | 1295 |
| living | 1292 |
| gastrointestinal | 1291 |
| science | 1291 |
| ad | 1290 |
| diabetic | 1289 |
| discussed | 1289 |
| workers | 1289 |
| lymphocytes | 1287 |
| prostate | 1287 |
| dynamics | 1287 |
| retrospectively | 1285 |
| requires | 1285 |
| vesicles | 1284 |
| fracture | 1282 |
| kinase | 1280 |
| regulated | 1280 |
| creatinine | 1279 |
| ischemic | 1275 |
| view | 1274 |
| crp | 1273 |
| intake | 1273 |
| diameter | 1271 |
| spinal | 1271 |
| recurrent | 1270 |
| pc | 1266 |
| nine | 1263 |
| produce | 1263 |
| isolation | 1262 |
| variability | 1262 |
| intra | 1261 |
| place | 1260 |
| network | 1260 |
| molecule | 1252 |
| oxidative | 1250 |
| involving | 1250 |
| wild | 1250 |
| allergy | 1248 |
| vein | 1246 |
| stimulated | 1239 |
| visual | 1238 |
| started | 1237 |
| pa | 1236 |
| mmol | 1235 |
| lactate | 1234 |
| removal | 1233 |
| occurrence | 1232 |
| cycle | 1231 |
| targeted | 1230 |
| adjusted | 1228 |
| serious | 1228 |
| far | 1227 |
| preparation | 1227 |
| find | 1224 |
| determination | 1222 |
| consent | 1222 |
| biomarkers | 1219 |
| matched | 1217 |
| reasons | 1216 |
| aspects | 1216 |
| ventricular | 1215 |
| bp | 1215 |
| placed | 1213 |
| consumption | 1212 |
| sodium | 1212 |
| tools | 1212 |
| goal | 1210 |
| past | 1209 |
| basic | 1209 |
| childhood | 1207 |
| hb | 1206 |
| focused | 1204 |
| replacement | 1203 |
| ray | 1202 |
| bladder | 1200 |
| anterior | 1200 |
| agreement | 1200 |
| vaccination | 1199 |
| prepared | 1197 |
| altered | 1197 |
| allowed | 1195 |
| fev | 1195 |
| origin | 1194 |
| met | 1193 |
| rhd | 1193 |
| documented | 1192 |
| receive | 1192 |
| subsequently | 1190 |
| migration | 1189 |
| recombinant | 1188 |
| channel | 1187 |
| logistic | 1187 |
| providing | 1185 |
| vessels | 1184 |
| section | 1184 |
| remain | 1183 |
| treat | 1182 |
| differ | 1177 |
| targets | 1176 |
| protocols | 1173 |
| bias | 1173 |
| benign | 1173 |
| promising | 1173 |
| na | 1172 |
| demographic | 1165 |
| gram | 1164 |
| nursing | 1163 |
| working | 1162 |
| necrosis | 1162 |
| added | 1162 |
| thyroid | 1162 |
| percent | 1162 |
| except | 1161 |
| residues | 1161 |
| graft | 1161 |
| organs | 1158 |
| biochemical | 1157 |
| matrix | 1157 |
| impairment | 1155 |
| tlr | 1155 |
| fact | 1154 |
| hla | 1151 |
| minimal | 1149 |
| great | 1149 |
| success | 1147 |
| curve | 1147 |
| sections | 1146 |
| survivors | 1146 |
| ns | 1145 |
| obstruction | 1145 |
| external | 1143 |
| preoperative | 1143 |
| cns | 1143 |
| qualitative | 1142 |
| estimate | 1141 |
| physician | 1139 |
| obtain | 1138 |
| gas | 1138 |
| adhesion | 1137 |
| existing | 1131 |
| biopsies | 1130 |
| membranes | 1130 |
| throughout | 1129 |
| saline | 1129 |
| efficient | 1128 |
| pi | 1127 |
| though | 1127 |
| already | 1126 |
| plus | 1125 |
| extracted | 1124 |
| fraction | 1123 |
| accumulation | 1123 |
| ranged | 1122 |
| protection | 1122 |
| sp | 1122 |
| progressive | 1121 |
| map | 1121 |
| showing | 1121 |
| inhibitory | 1117 |
| symptom | 1117 |
| mutant | 1117 |
| possibility | 1117 |
| multivariate | 1116 |
| impaired | 1116 |
| affinity | 1114 |
| obese | 1114 |
| december | 1112 |
| middle | 1111 |
| nutrition | 1111 |
| prospectively | 1111 |
| base | 1110 |
| nodes | 1109 |
| stages | 1107 |
| ab | 1106 |
| plays | 1106 |
| reliable | 1105 |
| genome | 1105 |
| validated | 1104 |
| core | 1102 |
| lateral | 1102 |
| efficiency | 1102 |
| inhibited | 1101 |
| standardized | 1100 |
| recruited | 1099 |
| ongoing | 1099 |
| diffusion | 1099 |
| manner | 1097 |
| ps | 1097 |
| recruitment | 1097 |
| hospitalization | 1094 |
| persistent | 1093 |
| alterations | 1093 |
| recognition | 1091 |
| immediately | 1091 |
| anxiety | 1090 |
| unclear | 1090 |
| mode | 1089 |
| independently | 1087 |
| crucial | 1086 |
| monitored | 1086 |
| complexes | 1086 |
| strength | 1085 |
| basal | 1085 |
| benefits | 1083 |
| challenges | 1078 |
| ischemia | 1078 |
| alcohol | 1078 |
| referred | 1077 |
| node | 1076 |
| applications | 1075 |
| fully | 1074 |
| initially | 1070 |
| account | 1069 |
| families | 1066 |
| neutrophils | 1066 |
| risks | 1065 |
| pe | 1065 |
| gel | 1064 |
| aki | 1061 |
| articles | 1058 |
| neonatal | 1057 |
| removed | 1057 |
| circulating | 1057 |
| bilateral | 1055 |
| represents | 1054 |
| atp | 1054 |
| id | 1054 |
| detailed | 1052 |
| lymphoma | 1050 |
| depending | 1050 |
| taking | 1049 |
| aeruginosa | 1048 |
| scans | 1047 |
| online | 1047 |
| appear | 1047 |
| scientific | 1047 |
| mitochondrial | 1047 |
| edema | 1045 |
| domains | 1044 |
| establish | 1043 |
| attention | 1043 |
| confirm | 1042 |
| observation | 1042 |
| confidence | 1042 |
| dental | 1041 |
| coagulation | 1041 |
| respect | 1041 |
| posterior | 1041 |
| wound | 1040 |
| sampling | 1040 |
| phosphorylation | 1040 |
| hospitalized | 1039 |
| act | 1039 |
| initiation | 1039 |
| practices | 1039 |
| electronic | 1038 |
| cortex | 1036 |
| measuring | 1036 |
| suitable | 1035 |
| tbi | 1035 |
| outbreak | 1035 |
| infl | 1033 |
| composition | 1032 |
| includes | 1031 |
| thoracic | 1030 |
| automated | 1030 |
| choice | 1030 |
| france | 1030 |
| mrsa | 1029 |
| close | 1028 |
| parents | 1025 |
| colorectal | 1023 |
| tomography | 1022 |
| correct | 1022 |
| collagen | 1022 |
| smoking | 1022 |
| metastatic | 1019 |
| resuscitation | 1019 |
| question | 1018 |
| paper | 1017 |
| anemia | 1016 |
| task | 1016 |
| output | 1016 |
| room | 1015 |
| investigations | 1015 |
| analyze | 1015 |
| cytometry | 1014 |
| cholesterol | 1014 |
| md | 1014 |
| probably | 1014 |
| characterization | 1011 |
| mic | 1010 |
| hernia | 1010 |
| mirnas | 1010 |
| marked | 1009 |
| reached | 1009 |
| enhancement | 1008 |
| distress | 1008 |
| medications | 1007 |
| panel | 1006 |
| achieve | 1005 |
| congenital | 1005 |
| improving | 1005 |
| sufficient | 1004 |
| albumin | 1003 |
| synthetic | 1003 |
| associations | 1003 |
| cant | 1001 |
| milk | 1001 |
| resources | 1000 |
| injected | 999 |
| cough | 999 |
| der | 999 |
| fixed | 999 |
| neutrophil | 998 |
| insertion | 997 |
| expressing | 997 |
| avoid | 996 |
| fast | 996 |
| take | 996 |
| near | 995 |
| technical | 995 |
| nf | 994 |
| eosinophils | 993 |
| ich | 993 |
| concerning | 992 |
| cr | 991 |
| deaths | 990 |
| particles | 990 |
| dietary | 990 |
| burden | 989 |
| aortic | 989 |
| magnetic | 987 |
| institution | 986 |
| aggregation | 986 |
| sub | 985 |
| economic | 985 |
| consisted | 985 |
| relationships | 984 |
| targeting | 983 |
| rapidly | 983 |
| ic | 983 |
| trend | 982 |
| thickness | 981 |
| interestingly | 981 |
| weak | 981 |
| delay | 980 |
| ventilator | 980 |
| beneficial | 979 |
| ventilated | 979 |
| cervical | 979 |
| hemodynamic | 978 |
| traditional | 977 |
| lungs | 976 |
| substrate | 975 |
| probe | 975 |
| completely | 975 |
| counts | 974 |
| exosomes | 974 |
| microglia | 974 |
| intracranial | 974 |
| synthesized | 973 |
| sectional | 973 |
| endoscopic | 972 |
| steroid | 971 |
| urban | 971 |
| yield | 971 |
| hemoglobin | 970 |
| surveillance | 970 |
| reviews | 969 |
| start | 969 |
| reason | 968 |
| complement | 968 |
| special | 967 |
| recognized | 966 |
| face | 966 |
| diffuse | 964 |
| transfusions | 964 |
| predictors | 964 |
| formed | 963 |
| degradation | 962 |
| mucosa | 962 |
| volunteers | 961 |
| consensus | 961 |
| sources | 960 |
| informed | 960 |
| power | 959 |
| allele | 959 |
| potent | 959 |
| implemented | 959 |
| evolution | 957 |
| heparin | 957 |
| introduced | 956 |
| space | 956 |
| placement | 954 |
| rs | 954 |
| feasible | 954 |
| assessing | 953 |
| cc | 953 |
| extended | 952 |
| sputum | 950 |
| regular | 950 |
| stored | 949 |
| ir | 948 |
| compound | 948 |
| promoter | 948 |
| pt | 947 |
| extensive | 947 |
| prediction | 946 |
| pilot | 946 |
| spread | 944 |
| discharged | 943 |
| devices | 943 |
| algorithm | 941 |
| ratios | 941 |
| failed | 940 |
| astrocytes | 940 |
| dm | 939 |
| visits | 939 |
| thought | 938 |
| exchange | 938 |
| rbcs | 936 |
| proximal | 936 |
| implications | 935 |
| profiles | 935 |
| superior | 935 |
| inhibit | 935 |
| mostly | 935 |
| neural | 934 |
| whose | 934 |
| mmp | 934 |
| soluble | 933 |
| tertiary | 933 |
| researchers | 932 |
| organization | 931 |
| arm | 931 |
| dementia | 930 |
| cortical | 929 |
| neck | 928 |
| odds | 927 |
| variant | 926 |
| limitations | 926 |
| excellent | 926 |
| intubation | 924 |
| occurring | 924 |
| channels | 923 |
| typical | 923 |
| icp | 923 |
| feeding | 923 |
| immediate | 922 |
| immunohistochemical | 921 |
| indicates | 920 |
| exclusion | 920 |
| fdg | 919 |
| called | 919 |
| recipients | 918 |
| address | 918 |
| tc | 918 |
| nutritional | 917 |
| thrombosis | 917 |
| digital | 916 |
| interpretation | 915 |
| earlier | 914 |
| approved | 914 |
| maintenance | 914 |
| angiography | 913 |
| cut | 913 |
| fusion | 912 |
| sensory | 912 |
| sleep | 912 |
| comprehensive | 911 |
| ar | 911 |
| document | 910 |
| morphology | 909 |
| causing | 908 |
| computed | 908 |
| primarily | 907 |
| clearly | 907 |
| layer | 907 |
| native | 905 |
| italy | 904 |
| validation | 904 |
| residents | 902 |
| metastases | 902 |
| evaluating | 902 |
| exhibited | 902 |
| estimates | 901 |
| elements | 900 |
| authority | 900 |
| always | 899 |
| educational | 899 |
| conclude | 897 |
| temporal | 897 |
| frailty | 897 |
| ranging | 897 |
| similarly | 896 |
| nervous | 895 |
| metastasis | 894 |
| american | 894 |
| changed | 894 |
| identifying | 894 |
| apache | 894 |
| limit | 894 |
| monoclonal | 893 |
| hormone | 893 |
| vap | 893 |
| fatty | 892 |
| asked | 892 |
| periods | 892 |
| consequences | 891 |
| spatial | 891 |
| characteristic | 891 |
| hcc | 891 |
| continued | 890 |
| balance | 888 |
| society | 886 |
| numerous | 886 |
| pharmacy | 885 |
| fluorescent | 885 |
| epithelium | 885 |
| possibly | 884 |
| concern | 879 |
| hypothesized | 879 |
| symptomatic | 879 |
| biology | 879 |
| reactivity | 878 |
| observations | 877 |
| purified | 876 |
| tm | 876 |
| matter | 876 |
| arteries | 876 |
| appeared | 876 |
| starting | 876 |
| journal | 876 |
| catheters | 875 |
| guidance | 874 |
| employed | 874 |
| vegf | 874 |
| residual | 873 |
| radiological | 873 |
| poorly | 873 |
| eye | 872 |
| ensure | 872 |
| transfused | 871 |
| defect | 870 |
| steps | 870 |
| thirty | 869 |
| systolic | 869 |
| toxic | 869 |
| monitor | 868 |
| focal | 868 |
| amyloid | 868 |
| conversion | 867 |
| se | 866 |
| feasibility | 866 |
| asymptomatic | 865 |
| force | 864 |
| sedation | 863 |
| paediatric | 863 |
| defects | 862 |
| version | 861 |
| liquid | 861 |
| screened | 860 |
| kit | 860 |
| malignancy | 858 |
| soft | 858 |
| false | 857 |
| heterogeneity | 857 |
| consider | 857 |
| items | 857 |
| equipment | 857 |
| mirna | 857 |
| signals | 856 |
| examinations | 856 |
| bed | 856 |
| roles | 856 |
| decline | 854 |
| random | 854 |
| gamma | 854 |
| pneumoniae | 854 |
| organisms | 853 |
| broad | 853 |
| acquisition | 852 |
| indications | 852 |
| localization | 851 |
| deficient | 851 |
| satisfaction | 850 |
| promote | 849 |
| barrier | 848 |
| easily | 848 |
| pelvic | 847 |
| parallel | 846 |
| cancers | 846 |
| tolerance | 845 |
| immunohistochemistry | 843 |
| longitudinal | 843 |
| guide | 843 |
| ion | 841 |
| carcinomas | 840 |
| bronchial | 840 |
| spectroscopy | 840 |
| requirements | 839 |
| availability | 839 |
| rectal | 839 |
| derivatives | 838 |
| perceived | 838 |
| ac | 837 |
| complicated | 837 |
| issue | 837 |
| ligand | 837 |
| guided | 836 |
| programs | 836 |
| minimum | 835 |
| affecting | 835 |
| radiology | 835 |
| scanning | 835 |
| initiated | 833 |
| city | 832 |
| eligible | 831 |
| emerging | 830 |
| prophylaxis | 830 |
| growing | 829 |
| needle | 828 |
| pr | 828 |
| ra | 827 |
| admissions | 827 |
| protease | 826 |
| enhance | 825 |
| china | 825 |
| define | 824 |
| chi | 824 |
| iqr | 823 |
| airways | 822 |
| delivered | 821 |
| height | 820 |
| dr | 820 |
| dept | 819 |
| intervals | 819 |
| ecmo | 817 |
| performing | 816 |
| tuberculosis | 816 |
| incubation | 816 |
| memory | 816 |
| maintain | 815 |
| reconstruction | 815 |
| los | 814 |
| contamination | 814 |
| transient | 814 |
| circulation | 814 |
| smooth | 813 |
| stomach | 813 |
| explore | 813 |
| ap | 812 |
| rh | 811 |
| variations | 811 |
| spleen | 811 |
| visit | 811 |
| record | 810 |
| proven | 810 |
| considering | 809 |
| maintained | 809 |
| younger | 809 |
| aa | 809 |
| load | 808 |
| committee | 808 |
| persons | 807 |
| sera | 807 |
| participation | 807 |
| etiology | 806 |
| indication | 806 |
| zinc | 805 |
| producing | 804 |
| plan | 804 |
| neuropathy | 803 |
| randomly | 803 |
| endogenous | 803 |
| genomic | 802 |
| policy | 802 |
| etc | 801 |
| specimen | 801 |
| placental | 801 |
| sciences | 801 |
| hypoxia | 801 |
| plants | 800 |
| weighted | 800 |
| predictor | 798 |
| supplementation | 797 |
| preventing | 797 |
| auc | 796 |
| arthritis | 796 |
| march | 796 |
| autoimmune | 796 |
| bound | 795 |
| clinicians | 795 |
| true | 795 |
| tg | 794 |
| give | 793 |
| monocytes | 793 |
| allergen | 793 |
| personal | 792 |
| appearance | 792 |
| details | 791 |
| gi | 791 |
| supply | 791 |
| drainage | 790 |
| reduces | 790 |
| disability | 790 |
| blot | 790 |
| created | 790 |
| neither | 788 |
| man | 787 |
| tgf | 786 |
| substantial | 785 |
| understood | 785 |
| concept | 785 |
| respondents | 784 |
| affects | 783 |
| threshold | 782 |
| constant | 782 |
| situation | 781 |
| solutions | 781 |
| stenosis | 779 |
| spect | 779 |
| infarction | 779 |
| minor | 779 |
| rise | 779 |
| induces | 778 |
| varied | 778 |
| vessel | 778 |
| transition | 777 |
| operating | 777 |
| gp | 777 |
| note | 776 |
| shorter | 776 |
| cox | 775 |
| immunity | 774 |
| newly | 774 |
| gland | 774 |
| descriptive | 773 |
| invasion | 773 |
| breathing | 773 |
| utilization | 772 |
| assigned | 772 |
| developmental | 772 |
| randomised | 772 |
| pathogenic | 772 |
| screen | 771 |
| esophageal | 771 |
| original | 771 |
| gain | 771 |
| resonance | 771 |
| standards | 770 |
| allowing | 770 |
| reach | 770 |
| repeat | 769 |
| smaller | 769 |
| joint | 768 |
| simulation | 768 |
| susceptible | 767 |
| slightly | 767 |
| challenging | 766 |
| stained | 766 |
| characterize | 765 |
| reveal | 765 |
| person | 765 |
| apoptotic | 764 |
| deep | 764 |
| definition | 763 |
| dissection | 763 |
| extraction | 762 |
| accepted | 762 |
| femoral | 762 |
| abo | 762 |
| bypass | 762 |
| murine | 761 |
| refractory | 761 |
| phenotypes | 761 |
| entry | 761 |
| worldwide | 760 |
| country | 760 |
| actin | 760 |
| doppler | 759 |
| perception | 759 |
| correlate | 758 |
| released | 757 |
| registered | 757 |
| advantages | 757 |
| exhibit | 756 |
| replication | 755 |
| mv | 753 |
| iu | 753 |
| turkey | 753 |
| gcs | 752 |
| determining | 751 |
| adopted | 751 |
| correlations | 751 |
| peep | 751 |
| morphological | 750 |
| typically | 750 |
| categories | 750 |
| shift | 750 |
| assisted | 750 |
| latter | 750 |
| pm | 749 |
| rr | 749 |
| dosage | 749 |
| exacerbations | 748 |
| signalling | 748 |
| seem | 748 |
| explain | 748 |
| staphylococcus | 747 |
| cmt | 746 |
| tokyo | 745 |
| probability | 745 |
| subjected | 745 |
| weaning | 745 |
| antioxidant | 744 |
| twice | 743 |
| rich | 743 |
| reverse | 743 |
| june | 742 |
| cantly | 742 |
| relevance | 742 |
| computer | 741 |
| laser | 741 |
| just | 740 |
| directed | 739 |
| hygiene | 739 |
| interleukin | 739 |
| dialysis | 739 |
| lab | 739 |
| easy | 738 |
| inter | 738 |
| epidemiological | 738 |
| sclerosis | 737 |
| regard | 736 |
| distance | 736 |
| canine | 736 |
| progress | 736 |
| prescribed | 735 |
| framework | 734 |
| thereby | 733 |
| prescription | 733 |
| million | 731 |
| separate | 731 |
| displayed | 730 |
| bile | 730 |
| icus | 729 |
| intraoperative | 729 |
| feedback | 729 |
| became | 728 |
| teaching | 727 |
| back | 727 |
| occlusion | 727 |
| hundred | 726 |
| addressed | 726 |
| ai | 726 |
| viability | 725 |
| resource | 725 |
| sah | 725 |
| cat | 725 |
| vector | 725 |
| rest | 725 |
| absorption | 725 |
| option | 724 |
| methodology | 723 |
| ethics | 723 |
| predicting | 723 |
| reliability | 722 |
| facilitate | 722 |
| skills | 722 |
| increasingly | 722 |
| surgeons | 722 |
| faculty | 721 |
| july | 721 |
| treating | 721 |
| contained | 720 |
| uid | 720 |
| barriers | 720 |
| contribution | 720 |
| errors | 719 |
| gold | 718 |
| ovarian | 718 |
| suppression | 717 |
| nosocomial | 717 |
| rejection | 716 |
| labeled | 716 |
| en | 716 |
| donations | 715 |
| title | 715 |
| efforts | 714 |
| managed | 713 |
| infiltration | 713 |
| comparative | 712 |
| hence | 712 |
| decreases | 712 |
| log | 711 |
| awareness | 711 |
| oxide | 711 |
| alveolar | 710 |
| europe | 710 |
| lc | 710 |
| eeg | 710 |
| entire | 710 |
| contain | 710 |
| chromatography | 710 |
| implicated | 710 |
| univ | 709 |
| sofa | 709 |
| seizures | 708 |
| kinetics | 708 |
| utilized | 708 |
| behaviour | 708 |
| exogenous | 706 |
| paired | 706 |
| display | 706 |
| academic | 705 |
| maximal | 705 |
| oxygenation | 705 |
| integrated | 705 |
| anesthesia | 705 |
| extremely | 704 |
| robotic | 703 |
| predominantly | 703 |
| providers | 703 |
| incubated | 703 |
| concerns | 703 |
| decreasing | 703 |
| und | 702 |
| modification | 702 |
| bpa | 702 |
| hrs | 701 |
| igm | 701 |
| fish | 700 |
| peritoneal | 699 |
| manual | 698 |
| pleural | 698 |
| express | 697 |
| atypical | 697 |
| cluster | 697 |
| considerable | 697 |
| valve | 697 |
| differentiated | 696 |
| tb | 696 |
| conformational | 696 |
| movement | 695 |
| coefficient | 695 |
| ages | 695 |
| amounts | 694 |
| minute | 694 |
| fed | 694 |
| professionals | 694 |
| cold | 693 |
| fungal | 692 |
| fragments | 691 |
| pharmaceutical | 691 |
| gm | 691 |
| indirect | 691 |
| intact | 691 |
| diagnoses | 691 |
| april | 691 |
| sustained | 690 |
| healing | 690 |
| follows | 690 |
| ex | 689 |
| closed | 689 |
| interstitial | 689 |
| exact | 689 |
| ckd | 688 |
| fresh | 688 |
| restricted | 688 |
| pulse | 688 |
| di | 687 |
| platform | 687 |
| regimen | 687 |
| valuable | 687 |
| registry | 686 |
| epidemiology | 686 |
| preterm | 686 |
| outside | 686 |
| square | 686 |
| specifi | 685 |
| positively | 685 |
| video | 685 |
| accompanied | 685 |
| experiment | 684 |
| identifi | 684 |
| candidate | 683 |
| mediators | 682 |
| concluded | 681 |
| rd | 681 |
| bal | 680 |
| pharmacological | 680 |
| sessions | 679 |
| consists | 678 |
| worse | 677 |
| pooled | 677 |
| written | 677 |
| participate | 676 |
| interferon | 676 |
| coupled | 675 |
| doi | 675 |
| ht | 674 |
| adenocarcinoma | 674 |
| serve | 674 |
| proteinuria | 674 |
| experiences | 673 |
| segment | 673 |
| block | 673 |
| duct | 673 |
| diverse | 673 |
| apparent | 672 |
| contains | 672 |
| subgroup | 672 |
| proved | 671 |
| ec | 671 |
| processed | 670 |
| adolescents | 670 |
| live | 670 |
| responders | 670 |
| consisting | 670 |
| corticosteroids | 670 |
| depends | 670 |
| equal | 670 |
| toward | 669 |
| cl | 669 |
| lv | 668 |
| validity | 668 |
| chloride | 668 |
| inhaled | 667 |
| behavioral | 666 |
| innate | 666 |
| anatomy | 666 |
| dosing | 665 |
| substances | 665 |
| alt | 665 |
| vital | 665 |
| mscs | 664 |
| glands | 663 |
| composed | 661 |
| aggressive | 660 |
| assessments | 660 |
| die | 659 |
| statistics | 659 |
| proper | 658 |
| volumes | 658 |
| utility | 658 |
| nd | 658 |
| anatomical | 658 |
| skeletal | 658 |
| absolute | 657 |
| concomitant | 657 |
| quantified | 657 |
| session | 657 |
| professional | 657 |
| absent | 657 |
| south | 656 |
| glutamate | 656 |
| mellitus | 656 |
| pao | 656 |
| planning | 655 |
| beyond | 655 |
| actual | 655 |
| reflect | 655 |
| grant | 655 |
| dog | 655 |
| nurse | 655 |
| bodies | 655 |
| synaptic | 654 |
| curves | 654 |
| multidisciplinary | 654 |
| blind | 653 |
| audit | 653 |
| uterine | 652 |
| demonstrates | 652 |
| distributed | 652 |
| commercial | 651 |
| gestation | 651 |
| transferred | 651 |
| modulation | 650 |
| woman | 649 |
| thrombin | 649 |
| lymphocyte | 649 |
| cytotoxic | 649 |
| relapse | 648 |
| sought | 648 |
| filtration | 648 |
| feature | 648 |
| polymorphism | 648 |
| detectable | 647 |
| scoring | 647 |
| beginning | 647 |
| lowest | 647 |
| foundation | 647 |
| parameter | 646 |
| remission | 646 |
| nucleotide | 646 |
| influenced | 646 |
| abdomen | 646 |
| obstructive | 645 |
| diarrhea | 645 |
| lg | 645 |
| recovered | 645 |
| operated | 645 |
| motion | 645 |
| steroids | 644 |
| anastomosis | 644 |
| decisions | 644 |
| ivig | 643 |
| spine | 643 |
| options | 643 |
| india | 642 |
| filter | 642 |
| simultaneously | 642 |
| largely | 642 |
| deletion | 642 |
| overexpression | 642 |
| improvements | 641 |
| regulate | 641 |
| extract | 641 |
| explored | 641 |
| phosphate | 640 |
| spain | 640 |
| exist | 640 |
| trained | 640 |
| tolerated | 639 |
| antiviral | 639 |
| spp | 639 |
| mesenchymal | 638 |
| rv | 637 |
| fio | 637 |
| nucleus | 637 |
| suffering | 636 |
| bl | 636 |
| explained | 636 |
| hd | 635 |
| manifestations | 635 |
| agonist | 634 |
| author | 634 |
| helpful | 634 |
| demographics | 633 |
| cp | 632 |
| discuss | 632 |
| closely | 632 |
| ethical | 632 |
| likelihood | 632 |
| improves | 632 |
| polymorphisms | 632 |
| untreated | 632 |
| percutaneous | 631 |
| publication | 631 |
| biomarker | 631 |
| category | 631 |
| eosinophilic | 630 |
| vaccines | 630 |
| mature | 630 |
| frozen | 630 |
| stimuli | 629 |
| degeneration | 628 |
| capable | 628 |
| antagonist | 627 |
| portal | 627 |
| speed | 627 |
| nevertheless | 626 |
| slow | 626 |
| detecting | 625 |
| pancreatitis | 625 |
| mutants | 625 |
| microbial | 625 |
| stent | 625 |
| submitted | 624 |
| resolved | 624 |
| typing | 624 |
| partially | 624 |
| situ | 623 |
| sensitization | 622 |
| anova | 622 |
| semi | 622 |
| macrophage | 622 |
| minimally | 622 |
| robust | 621 |
| never | 621 |
| injured | 621 |
| intermediate | 621 |
| radical | 620 |
| localized | 620 |
| cavity | 620 |
| involves | 620 |
| ward | 619 |
| cirrhosis | 619 |
| mucosal | 618 |
| dc | 618 |
| optical | 618 |
| msc | 618 |
| pseudomonas | 618 |
| rarely | 617 |
| ha | 615 |
| leukemia | 615 |
| eosinophil | 615 |
| indeed | 615 |
| ligands | 615 |
| undergo | 615 |
| lacking | 615 |
| error | 614 |
| sec | 614 |
| oncology | 614 |
| outpatient | 613 |
| annual | 613 |
| technologies | 613 |
| identical | 613 |
| carbon | 613 |
| fixation | 612 |
| turn | 612 |
| correction | 611 |
| fasting | 611 |
| ndings | 611 |
| article | 610 |
| practical | 610 |
| hyperplasia | 609 |
| nearly | 609 |
| routinely | 609 |
| equivalent | 609 |
| extracts | 608 |
| microorganisms | 608 |
| expansion | 607 |
| indicators | 607 |
| hsp | 606 |
| return | 606 |
| instead | 606 |
| hbsag | 606 |
| elevation | 606 |
| bind | 605 |
| know | 605 |
| phenomenon | 605 |
| chemistry | 605 |
| ones | 605 |
| comparisons | 605 |
| roc | 605 |
| sc | 604 |
| retinal | 604 |
| generate | 603 |
| fc | 603 |
| mentioned | 603 |
| thrombocytopenia | 603 |
| member | 603 |
| participant | 602 |
| limb | 602 |
| blinded | 602 |
| exacerbation | 601 |
| ki | 601 |
| raised | 600 |
| endotoxin | 600 |
| axis | 600 |
| pct | 600 |
| preferred | 599 |
| hip | 599 |